Hester Biosciences Limited

NSE HESTERBIO.NS

Hester Biosciences Limited Revenue Per Share for the year ending March 31, 2024: USD 4.29

Hester Biosciences Limited Revenue Per Share is USD 4.29 for the year ending March 31, 2024, a 12.78% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Hester Biosciences Limited Revenue Per Share for the year ending March 31, 2023 was USD 3.81, a 4.60% change year over year.
  • Hester Biosciences Limited Revenue Per Share for the year ending March 31, 2022 was USD 3.64, a 5.74% change year over year.
  • Hester Biosciences Limited Revenue Per Share for the year ending March 31, 2021 was USD 3.44, a 20.36% change year over year.
  • Hester Biosciences Limited Revenue Per Share for the year ending March 31, 2020 was USD 2.86, a -5.09% change year over year.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
Loading...
NSE: HESTERBIO.NS

Hester Biosciences Limited

CEO Mr. Rajiv Dinesh Gandhi B.Com
IPO Date March 13, 2015
Location India
Headquarters Pushpak
Employees 642
Sector Health Care
Industries
Description

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates in two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for diseases, such as newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian encephalomyelitis, etc. It also offers vaccines for large animals comprising Goat Pox, Peste des Petits Ruminants, Brucellosis, Mastitis, Metritis, and various infectious diseases, as well as infections, reproductive disorders, theileriosis, parasitic diseases, etc. In addition, the company provides feed supplements, such as toxin binder, trace minerals, enzyme preparation, and bypass fat; disinfectants for farms and equipment, and water sanitizers; nutrition products consisting of mineral mixtures, fertility supplements, and growth tonics; and herbal products, including growth promoters, herbal replacers for choline chloride, stress relievers and immunity boosters, respiratory stimulants, liver tonics, wound healing preparations, uterine tonics, digestive tonics and anti-bloat solutions, ectoparasiticide preparations, anti-mastitis, and anti-prolapse preparations. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.

Similar companies

JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited

USD 20.35

-1.23%

SHILPAMED.NS

Shilpa Medicare Limited

USD 9.00

6.34%

CAPLIPOINT.NS

Caplin Point Laboratories Limited

USD 26.96

3.45%

NEULANDLAB.NS

Neuland Laboratories Limited

USD 153.69

1.58%

ERIS.NS

Eris Lifesciences Limited

USD 14.77

2.53%

StockViz Staff

January 15, 2025

Any question? Send us an email